Articles from Carna Health

Carna Health, a digital health company revolutionizing kidney care and related cardio-kidney metabolic (CKM) conditions, announced the expansion of its global chronic kidney disease (CKD) screening programs on World Kidney Day. Leveraging AI-enabled early detection and follow-up care, Carna Health is scaling initiatives across multiple regions to identify CKD before it reaches advanced stages and connect patients with timely treatment.

Carna Health, a digital health company revolutionizing kidney care, today announced an $8M capital raise to expand global access to its kidney screening technology. The round included participation from Dr. Jay Rosan, Cenk Bekmezçi, Jose Pereyra, Mark Boulding, Brandon Salomon, Andrew Roosevelt, Jeff Lindsey, Joseph White, John Brooks, Elvis Ndansi and Dr. Salvatore Viscomi.

Carna Health, a digital health company revolutionizing kidney care, announced a strategic agreement with Siemens Healthineers to accelerate adoption of Carna’s AI-enabled chronic kidney disease (CKD) platform and bring industry-leading point of care testing systems to emerging markets. The agreement aims to improve early detection and CKD management for high-risk and underserved populations by integrating Carna Health’s digital platforms with Siemens Healthineers global diagnostics infrastructure. It also aims to simplify CKD workflow processes, creating better pathways for referrals and providing timely nephrology care to improve patient outcomes while reducing healthcare costs for both patients and healthcare systems.

Carna Health, a digital health company revolutionizing kidney care, released findings from a pilot program aimed at slowing progression of CKD in Cameroon. Launched during World Kidney Week in April alongside renowned nephrologist Dr. Ronald Gobina, the program achieved remarkable success, surpassing its screening goal within three days with more than 550 participants.

Carna Health, a digital health company transforming kidney care, today named its leadership team and released results from a chronic kidney disease (CKD) screening program in Bermuda as the first international recipient of a grant from the Bermuda Health Council Innovation Program. Launched in 2021, Boston-based Carna Health’s mission is to help slow the global progression of CKD, which is projected to be the fifth highest cause of death globally by 2040.i Carna Health provides integrated point-of-care testing solutions with its medical device partner Nova Biomedical and an artificial intelligence (AI)-driven software platform to improve CKD screening, monitoring, and care management.